Rekombinanter NAPSA Antikörper (AA 189-299)
-
- Target Alle NAPSA Antikörper anzeigen
- NAPSA (Napsin A Aspartic Peptidase (NAPSA))
- Antikörpertyp
- Recombinant Antibody
-
Bindungsspezifität
- AA 189-299
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser NAPSA Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC)
- Immunogen
- Recombinant human Napsin-A protein fragment (aa189-299) (exact sequence is proprietary)
- Klon
- MSVA-112R
- Isotyp
- IgG
- Top Product
- Discover our top product NAPSA Primärantikörper
-
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 20-158) antibody
NAPSA Reaktivität: Human WB, ELISA, IHC Wirt: Maus Monoclonal 10C4B8 unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human WB, IHC, IF, FACS, StM Wirt: Maus Monoclonal NAPSA-1238 unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 25-250) antibodyNAPSA Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 64-420) antibodyNAPSA Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) antibodyNAPSA Reaktivität: Human, Maus WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human IHC, StM Wirt: Maus Monoclonal NAPSA-3309 unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 368-397), (C-Term) antibodyNAPSA Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB33879 unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human WB, IHC, IF, FACS, StM Wirt: Maus Monoclonal NAPSA-1238-NAPSA-1239 unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human IHC, StM Wirt: Kaninchen Monoclonal NAPSA-1865R unconjugated Recombinant Antibody
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human IHC, StM Wirt: Maus Monoclonal rNAPSA-1239 unconjugated Recombinant Antibody
-
- Applikationshinweise
- IHC 1:100-1:200
- Kommentare
-
Positive Control: Kidney: an at least moderate granular cytoplasmic staining should be seen in proximal tubule cells
Negative Control: Colon: staining should be absent in epithelial and other cells of the lamina propria.
- Protokoll
- Manual Protocol: Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121 °C in pH 7,8 Target Retrieval Solution buffer. Apply the antibody at a dilution of 1:150 at 37 °C for 60 minutes. Visualization of bound antibody by the EnVision Kit (Dako, Agilent) according to the manufacturer's directions.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Lagerung
- 4 °C,-20 °C,-80 °C
- Informationen zur Lagerung
- Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non- hazardous.
-
- Target
- NAPSA (Napsin A Aspartic Peptidase (NAPSA))
- Andere Bezeichnung
- Napsin A (NAPSA Produkte)
- Synonyme
- KAP antikoerper, Kdap antikoerper, NAP1 antikoerper, NAPA antikoerper, SNAPA antikoerper, pronapsin antikoerper, kap antikoerper, kdap antikoerper, nap1 antikoerper, napa antikoerper, napsa antikoerper, snapa antikoerper, napsin A aspartic peptidase antikoerper, napsin A aspartic peptidase L homeolog antikoerper, NAPSA antikoerper, Napsa antikoerper, napsa.L antikoerper
- Hintergrund
- ASP4, Aspartyl protease 4, KAP, Kidney derived aspartic protease like protein (Kdap), NAP1, NAPA, Napsa, napsin A aspartic peptidase, Pronapsin A, SNAPA,Napsin A antibody validated for immunohistochemistry on 76 different Normal Tissues
- UniProt
- O96009
- Pathways
- Tube Formation, Asymmetric Protein Localization, Embryonic Body Morphogenesis
-
